Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
60.684,53
-0,18%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ BELLUS Health Inc (BLU) BELLUS Health Inc (BLU) Notizie

BLU

BELLUS Health (BLU)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BLU
DataOraFonteTitoloSimboloCompagnia
30/01/202416:56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLUBELLUS Health Inc
14/08/202323:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLUBELLUS Health Inc
10/07/202314:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:BLUBELLUS Health Inc
28/06/202323:22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BLUBELLUS Health Inc
28/06/202323:21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLUBELLUS Health Inc
28/06/202322:11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:BLUBELLUS Health Inc
28/06/202322:10Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:BLUBELLUS Health Inc
28/06/202320:42Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLUBELLUS Health Inc
28/06/202317:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
28/06/202316:59PR Newswire (Canada)Annonce boursière - Réservée aux médias et aux investisseurs - GSK mène à terme l'acquisition de BELLUS SantéNASDAQ:BLUBELLUS Health Inc
28/06/202316:57PR Newswire (Canada)Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS HealthNASDAQ:BLUBELLUS Health Inc
16/06/202319:50Business WireBELLUS Health Inc. Announces Voting Results from Special Meeting of ShareholdersNASDAQ:BLUBELLUS Health Inc
16/06/202319:50Business WireBELLUS Santé inc. annonce les résultats du vote tenu à l’assemblée extraordinaire des actionnairesNASDAQ:BLUBELLUS Health Inc
16/05/202323:01Business WireBELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK AcquisitionNASDAQ:BLUBELLUS Health Inc
16/05/202323:01Business WireBELLUS Santé inc. convoque une assemblée extraordinaire des actionnaires concernant l’acquisition de la société par GSKNASDAQ:BLUBELLUS Health Inc
12/05/202322:01Business WireBELLUS Santé annonce ses résultats financiers et faits saillants pour le premier trimestre de 2023NASDAQ:BLUBELLUS Health Inc
12/05/202322:01Business WireBELLUS Health Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:BLUBELLUS Health Inc
27/04/202300:00Business WireBELLUS Health Announces Meeting UpdatesNASDAQ:BLUBELLUS Health Inc
27/04/202300:00Business WireBELLUS Santé annonce de l’information récente au sujet de l’assembléeNASDAQ:BLUBELLUS Health Inc
18/04/202318:11Business WireGSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS HealthNASDAQ:BLUBELLUS Health Inc
18/04/202316:42Dow Jones NewsBellus Health Toronto-Listed Shares Double on GSK TakeoverNASDAQ:BLUBELLUS Health Inc
18/04/202312:30Dow Jones NewsTrending: GSK Buys Bellus Health for About $2 BillionNASDAQ:BLUBELLUS Health Inc
18/04/202312:24Dow Jones NewsBellus Health Shares Soar Premarket on Takeover by GSKNASDAQ:BLUBELLUS Health Inc
05/04/202313:00Business WireBELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release FormulationNASDAQ:BLUBELLUS Health Inc
05/04/202313:00Business WireBELLUS Santé annonce les résultats positifs de son étude d’équivalence de la biodisponibilité de phase 1 comparant la formule à libération prolongée et à dose quotidienne unique du camlipixant avec la formule à libération immédiate...NASDAQ:BLUBELLUS Health Inc
30/03/202322:06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BLUBELLUS Health Inc
23/03/202321:49Edgar (US Regulatory)Annual Report (foreign Private Issuer) (40-f)NASDAQ:BLUBELLUS Health Inc
21/03/202321:30Business WireBELLUS Health Reports Year 2022 Financial Results and Business HighlightsNASDAQ:BLUBELLUS Health Inc
21/03/202321:30Business WireBELLUS Santé annonce ses résultats financiers et faits saillants pour l’exercice 2022NASDAQ:BLUBELLUS Health Inc
01/03/202313:00Business WireBELLUS Health to Participate in the Cowen 43rd Annual Health Care ConferenceNASDAQ:BLUBELLUS Health Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BLU

La tua Cronologia

USOTC
PLSI
Phoenix Life Sciences (CE)
BIT
UI074B
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network